Moxi by Emulate | Clive Roper | Activity https://dev.moxi.clayglobaldev.com/members/cliveropertcl-com/activity/ Activity feed for Clive Roper. Mon, 08 May 2023 09:36:04 -0400 https://buddypress.org/?v=2.3.3 en-US 30 hourly 2 a86894369357152fd9200515a2d795b8 Clive Roper replied to a discussion in the forum *Announcements https://dev.moxi.clayglobaldev.com/forums/topic/get-your-free-moxi-mug/#post-836 Wed, 28 Dec 2022 14:13:43 -0500 Reply to Get your free Moxi mug!

Congrats on 6 months of Moxi. It’s time for a well deserved coffee break.

]]> c2b4aebfd067fb84db6d59bd44b8abce Clive Roper posted a new activity comment https://dev.moxi.clayglobaldev.com/activity/p/687/#acomment-718 Mon, 17 Oct 2022 16:10:33 -0400 It hasn’t been formally announced, but I am presenting on this topic at the Association of Inhalation Toxicologists meeting in Gothenburg in May 2023. We hope that the text in the considerations section is clear enough for people to follow our ideas.

In reply to - Clive Roper posted an update Our case study for respiratory toxicology NAM was published in September and the link is here – https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/cbc/mono(2022)3 […] ]]> 6f2f0216c2a5f547cddfbe9af231cb46 Clive Roper posted a new activity comment https://dev.moxi.clayglobaldev.com/activity/p/687/#acomment-693 Mon, 10 Oct 2022 16:54:48 -0400 Hi Stephen
The case study has all of the formal publications cited and it includes citations to the US EPA meetings and their final risk assessment. We felt it was important to highlight it as an OECD for a few reasons including it used a series of different technologies together to create the NAM, it involved key stakeholders (i.e., discussion… Read more

In reply to - Clive Roper posted an update Our case study for respiratory toxicology NAM was published in September and the link is here – https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/cbc/mono(2022)3 […] ]]> 639bc5306230848b9fe98da09bbea01f Clive Roper posted an update: Our case study for respiratory toxicology NAM was published […] https://dev.moxi.clayglobaldev.com/activity/p/687/ Fri, 07 Oct 2022 18:06:26 -0400 Our case study for respiratory toxicology NAM was published in September and the link is here – https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/cbc/mono(2022)31&doclanguage=en
The use of Case Studies strengthens the evidence that the new approach methods and MPS technologies are the way forward. If you would like to know… Read more

]]> 4 051c70023454df9383b794e04b314e06 Clive Roper replied to a discussion in the forum Lung https://dev.moxi.clayglobaldev.com/forums/topic/modeling-pulmonary-cystic-fibrosis-in-a-human-lung-airway-on-a-chip/#post-672 Fri, 17 Jun 2022 10:29:34 -0400 Reply to Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip

I gave a short presentation on a poster for CF using the MucilAIr CF model, you can watch it using this link: Assessment of Mucociliary Clearance and Cilia Beating Frequency in MucilAir (TM) – Cystic Fibrosis In Vitro | Charles River (criver.com). There is a poster as well. If you would like a copy, contact me at Clive@RoperTCL.com.

]]> 953190c28cf5acdf959e99d67783a86f Clive Roper started a new discussion in the forum Lung https://dev.moxi.clayglobaldev.com/forums/topic/immuone-immune-competent-models/ Wed, 01 Jun 2022 13:29:24 -0400 ImmuONE - immune competent models

Hi

ImmuONE have developed immune competent models for toxicology testing in the lower airway. They can also run these in parallel with commercial upper airway models. If you want to know more, contact Abigail Martin (abigail.martin@immuone.com).

Thanks Clive

 

]]> 522e3d7a852e97e6b03e4f2489724a61 Clive Roper started a new discussion in the forum Eye https://dev.moxi.clayglobaldev.com/forums/topic/acellz-new-model-under-development/ Wed, 01 Jun 2022 13:26:33 -0400 ACellZ - new model under development

ACellZ are developing a new 3D model for use in ocular testing. The difference is that they have an immune component incorporated into the model. My contact is Heraldas Gaspariunas (h.gaspariunas@acellz.co.uk). He is looking for partnerships to further develop and test the model including chemicals, failed and successfully registered ophthalmic… Read more

]]> d85de2626106fb10ee4a64ae76f7ec89 Clive Roper replied to a discussion in the forum Tumor https://dev.moxi.clayglobaldev.com/forums/topic/how-to-create-the-chip-which-can-seed-the-primary-tumor/#post-651 Wed, 01 Jun 2022 13:22:53 -0400 Reply to How to create the chip which can seed the primary tumor

Hi Tran

You could try contacting Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs – Aracari Biosciences. My main contact there is Ming-i Huang (ming-i.huang@aracaribio.com).

Kind regards

Clive

]]>